2-phenyl-4-quinazolinone compounds, 2-phenyl-4-alkoxy-quinazoline compounds and their pharmaceutical compositions
申请人:National Science Council
公开号:US06479499B1
公开(公告)日:2002-11-12
Two series of 6,7,2′,3′,4′,5′-substituted 2-phenyl-4-quinazolinones and 6,2′,3′,4′,5′-substituted 2,3-dihydro-2-phenyl-4-quinazolinones are synthesized and evaluated for cytotoxicity against a panel of human tumor cell lines, such as epidermoid carcinoma of the nasopharynx (KB), lung carcinoma (A-549), ileocecal carcinoma (HCT-8), breast cancer (MCF-7), melanoma (SKMEL-2), ovarian cancer (1A9), glioblastoma (U-87-MG), bone (HOS), P-gp-expressing epidermoid carcinoma of the nasopharynx (KB-VIN), and prostate cancer (PC3) cell lines, and some of the compounds are found potent. The present invention also synthesizes 2-phenyl-4-alkoxy-quinazoline compounds, wherein some of the compounds exhibit antiplatelet activity.
合成了两系列6,7,2′,3′,4′,5′-取代的2-苯基-4-喹唑啉酮和6,2′,3′,4′,5′-取代的2,3-二氢-2-苯基-4-喹唑啉酮,并对它们进行了细胞毒性评估,针对人类肿瘤细胞系,如鼻咽癌表皮样癌(KB)、肺癌(A-549)、回肠癌(HCT-8)、乳腺癌(MCF-7)、黑色素瘤(SKMEL-2)、卵巢癌(1A9)、胶质母细胞瘤(U-87-MG)、骨癌(HOS)、表达P-gp的鼻咽癌表皮样癌(KB-VIN)和前列腺癌(PC3)细胞系,其中一些化合物显示出潜在的细胞毒性。本发明还合成了2-苯基-4-烷氧基-喹唑啉化合物,其中一些化合物表现出抗血小板活性。